Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor most people, Mounjaro side effects do improve with time. The gastrointestinal symptoms that tend to appear early (nausea, loose stools, indigestion) are typically most noticeable in the first days after a new dose and settle considerably within one to two weeks as your body adjusts. That pattern holds across most dose increases too, not just the first pen. Mounjaro (tirzepatide) is a prescription-only medicine, and a GPhC-registered prescriber reviews your full picture before treatment starts — side effects, timing, and how to manage them are all part of that conversation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The side effects people notice most often with Mounjaro are driven by the way tirzepatide slows gastric emptying and acts on appetite signals. Nausea is the most reported, followed by constipation, diarrhoea, vomiting, and that uncomfortable fullness that makes a normal meal feel enormous. According to the NHS tirzepatide medicines page, these effects are common but tend to be mild to moderate and improve as treatment continues.
The practical timeline most prescribers describe goes something like this: the first week or two after starting (or after stepping up to a new strength) is when symptoms peak. By weeks three and four, most people find things have calmed down enough to feel manageable. Some people breeze through with almost nothing; others have a rougher first fortnight. Neither experience is unusual. The likelihood of getting side effects varies considerably between individuals, and there is no reliable way to predict in advance who will feel what.
Eating smaller portions, avoiding greasy or very rich foods, and staying well hydrated genuinely help. Injecting on a consistent day each week also matters, fitting it into a regular routine (some people choose Sunday evening so they are past the peak before the working week) makes the pattern easier to anticipate.
Yes, it can. Each time the dose steps up, your system is adapting to a higher level of drug activity, so a mild recurrence of early symptoms is common. The good news is that each recurrence tends to be shorter and less intense than the first, because your body has already done most of the adjusting. This is one reason the licensed titration schedule starts at 2.5 mg (a dose designed to help your system settle, not to deliver the full therapeutic effect straight away) and moves gradually upward in stages guided by your prescriber.
If side effects at any dose remain significant after two or three weeks, that is worth raising with your clinical team rather than waiting it out. Staying at a current dose for longer before stepping up is sometimes the right call, and it is a conversation rather than a failure. You can read more about when side effects typically appear at each stage of treatment, which can help set realistic expectations before you even open the first pen.
For people curious about how Mounjaro's side-effect profile compares with alternative medicines, the comparison with retatrutide's side effects covers what early trial data suggests about the differences.
Most Mounjaro side effects are inconvenient rather than dangerous. A handful are not. In January 2026, the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis as a known, infrequent but potentially serious effect of GLP-1 medicines including tirzepatide. The warning sign is severe stomach pain that does not go away and may spread through to your back, with or without vomiting. That combination needs same-day emergency assessment, not a message to your online prescriber, but 999 or A&E.
Other symptoms that warrant prompt contact with a healthcare professional rather than waiting for your next review: signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing), symptoms suggesting gallbladder problems (sharp pain in the upper right abdomen, especially after eating), and any sustained vomiting or diarrhoea that is preventing you from keeping fluids down, since dehydration can strain the kidneys. Low mood or any thoughts of self-harm should also be raised with a doctor without delay.
If you are unsure whether what you are experiencing needs urgent attention, NHS 111 is a reasonable first call. And if you suspect your symptoms may be a reaction to the medicine, you can report them directly through the Yellow Card scheme, patient reports genuinely inform how regulators monitor these medicines over time.
Understanding that most side effects follow a predictable arc (present early, often easing within a fortnight, then manageable through the titration stages) changes the calculation for a lot of people. It is not a reason to dismiss discomfort, but it does mean that a difficult first two weeks rarely predicts how week eight or month six will feel.
The full Mounjaro side-effects guide covers every listed effect with frequencies drawn from the clinical data. If you want a closer look at what the 5 mg stage specifically tends to bring, that is covered separately. And if you are weighing up whether this treatment is the right fit for your health picture overall, the Mounjaro overview pulls together efficacy, eligibility and how the medicine works.
At nume, our prescribers go through side effects, timing and your individual health history during the free consultation, that is the point of a clinical review rather than a tick-box form. If treatment is appropriate, you hear it from a person who has read your answers, not from an automated response. Check your eligibility and start that conversation with no obligation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.